Effect of CI-988, a cholecystokinin-B receptor antagonist, on lactate-induced panic

Biological Psychiatry

Volumn 40, Issue 6, 1996, Pages 550-552

  Cowley, Deborah S ^a,d   Adams, Judith Bammert ^b   Pyke, Robert E ^c   Cook, Jack ^b   Zaccharias, Pam ^a   Wingerson, Dane ^a   Roy Byrne, Peter P ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b PFIZER INC   (United States)

^c Kendle Research Associates   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Cholecystokinin; Cholecystokinin B receptor; Lactate; Panic

Indexed keywords

4 [[2 [2 [[(2 ADAMANTYLOXY)CARBONYL]AMINO] 3 (1H INDOL 3 YL) 2 METHYLPROPIONAMIDO] 1 PHENYLETHYL]AMINO] 4 OXOBUTYRIC ACID MEGLUMINE; CHOLECYSTOKININ; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; LACTIC ACID; PLACEBO;

ADULT; AGORAPHOBIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; PANIC; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030587390     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(96)00163-1     Document Type: Article

References (10)

1. Bammert Adams J, Pyke RE, Costa J, et al (1995): A double-blind, placebo-controlled study of a CCK-B receptor antagonist, CI-988, in patients with generalized anxiety disorder. J Clin Psychopharmacol 15:428-434.
2. Bradwejn J, Koszycki D, Shriqui C (1991): Enhanced sensitivity to cholecystokinin-tetrapeptide in panic disorder: Clinical and behavioral findings. Arch Gen Psychiatry 48:603-610.
3. Bradwejn J, Koszycki D, Couetoux du Tetre A, et al (1994a): The panicogenic effects of cholecystokinin tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder. Arch Gen Psychiatry 51:486-493.
4. Bradwejn J, Paradis M, Koszycki D, Reece P, Sedman A (1994b): The effects of CI-988 on CCK-4-panic in healthy volunteers. Presented at the annual meeting of the ACNP.
5. Cowley D, Arana G (1990): The diagnostic utility of lactate sensitivity in panic disorder. Arch Gen Psychiatry 47:277-284.
6. Powell KR, Barrett JE (1991): Evaluation of the effects of PD 134308 (CI-988), a CCK-B antagonist, on the punished responding of squirrel monkeys. Neuropeptides 19(suppl): 75-78.
7. Singh L, Field M, Hughes J, et al (1991a): The behavioural properties of CI-988, a selective cholecystokinin B receptor antagonist. Br J Pharmacol 104:239-245.
8. Singh L, Lewis A, Field M, Hughes J, Woodruff G (1991b): Evidence for an involvement of the brain cholecystokinin B receptor in anxiety. Proc Natl Acad Sci USA 88:1130-1133.
9. Van der Molen GM, van den Hout MA, Vroeman J, Lousberg H, Griez E (1986): Cognitive factors in lactate-induced anxiety. Behav Res Ther 24:677-680.
10. Westenberg H, van Megen HGM, den Boer JA (1994): Effect of the cholecystokinin-B receptor antagonist L-365,260 on lactate-induced panic in panic disorder (PD) patients. Psychopharmacol Bull 30:644.